TNFRSF10A and urothelial carcinoma: Analysis of immunohistochemical expression of DR4 and DR5 on paraffin samples of 229 bladder tumors obtained by TURBT showed that these markers were expressed in 75.1% and 74.2% of urothelial carcinomas, respectively [31].